The monoacylglycerol acyltransferase 2 inhibitor VB-85387 reduces MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) arises from the accumulation of triglycerides within the liver. MASLD can advance to metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and hepatocellular carcinoma. Monoacylglycerol acyltransferase 2 (MOGAT2) is essential for triglycerid...